Ibrutinib-d5

CAT: 0804-HY-10997S-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-10997S-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Ibrutinib-d5 (PCI-32765-d5) is a deuterium labeled Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor[1].
CAS Number
[1553977-17-5]
Product Name Alternative
PCI-32765-d5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Btk
Type
Isotope-Labeled Compounds
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.08
Solubility
10 mM in DMSO|DMF : ≥ 30mg/mL|DMSO : ≥ 30mg/mL|Ethanol : ≥ 0.25mg/mL
Smiles
C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=C([2H])C([2H])=C([2H])C([2H])=C4[2H])C=C3)C5=C(N)N=CN=C52)CCC1)=O
Molecular Formula
C25H19D5N6O2
Molecular Weight
445.53
Precautions
H302, H315, H319, H335
References & Citations
[1]Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107 (29) :13075-80.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-10997-01Ibrutinib
HY-100659-01Dihydrodiol-Ibrutinib
HY-100342-01Ibrutinib-biotin
HY-10997R-01Ibrutinib (Standard)
HY-78727-01Ibrutinib deacryloylpiperidine
HY-43521-01Ibrutinib-MPEA
HY-136113-01Ibrutinib dimer
HY-10997A-01Ibrutinib (Racemate)
HY-Z2289-01Ibrutinib impurity 5
HY-15809-01(Rac) -Ibrutinib alkyne

Alternative Products

CatalogName
sc-495736AIbrutinib-d5
RM-I182027-01Ibrutinib D5
sc-495538(S) -Ibrutinib-d5
166441S-Ibrutinib-d5
446995-01Dihydrodiol Ibrutinib-d5
TRC-I124977-25MG(S)-Ibrutinib-d5
GP8742-25mgIbrutinib

Popular Products